These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 31524669)

  • 1. Association of total bilirubin with contrast-induced nephropathy in patients with acute ST-elevation myocardial infarction after percutaneous coronary intervention.
    Luo E; Wang D; Qiao Y; Zhu B; Liu B; Hou J; Tang C
    Coron Artery Dis; 2020 Jan; 31(1):92-94. PubMed ID: 31524669
    [No Abstract]   [Full Text] [Related]  

  • 2. Routine iso-osmolar contrast media use and acute kidney injury following percutaneous coronary intervention for ST elevation myocardial infarction.
    Premawardhana D; Sekar B; Ul-Haq MZ; Sheikh A; Gallagher S; Anderson R; Copt S; Ossei-Gerning N; Kinnaird T
    Minerva Cardioangiol; 2019 Oct; 67(5):380-391. PubMed ID: 31527583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Acute Kidney Injury in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
    Velibey Y; Oz A; Tanik O; Guvenc TS; Kalenderoglu K; Gumusdag A; Akdeniz E; Bozbay M; Tekkesin AI; Guzelburc O; Hayiroglu MI; Alper AT; Ugur M; Eren M
    Angiology; 2017 May; 68(5):419-427. PubMed ID: 27473864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contrast Volume to Glomerular Filtration Ratio and Acute Kidney Injury among ST-Segment Elevation Myocardial Infarction Patients Treated with Primary Percutaneous Coronary Intervention.
    Zahler D; Rozenfeld KL; Merdler I; Peri Y; Shacham Y
    Cardiorenal Med; 2020; 10(2):108-115. PubMed ID: 31801134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of neutrophil gelatinase-associated lipocalin and cystatin C as biomarkers of acute kidney injury after ST-segment elevation myocardial infarction treated by percutaneous coronary intervention.
    Nguyen LS; Spagnoli V; Kerneis M; Hauguel-Moreau M; Barthélémy O; Collet JP; Montalescot G; Silvain J
    Arch Cardiovasc Dis; 2019 Mar; 112(3):180-186. PubMed ID: 30639197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute Kidney Injury After Primary Angioplasty: Is Contrast-Induced Nephropathy the Culprit?
    Caspi O; Habib M; Cohen Y; Kerner A; Roguin A; Abergel E; Boulos M; Kapeliovich MR; Beyar R; Nikolsky E; Aronson D
    J Am Heart Assoc; 2017 Jun; 6(6):. PubMed ID: 28647690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-induced acute kidney injury and mortality in ST elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Silvain J; Nguyen LS; Spagnoli V; Kerneis M; Guedeney P; Vignolles N; Cosker K; Barthelemy O; Le Feuvre C; Helft G; Collet JP; Montalescot G
    Heart; 2018 May; 104(9):767-772. PubMed ID: 29092921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Centola M; Lucreziotti S; Salerno-Uriarte D; Sponzilli C; Ferrante G; Acquaviva R; Castini D; Spina M; Lombardi F; Cozzolino M; Carugo S
    Int J Cardiol; 2016 May; 210():4-9. PubMed ID: 26921538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between copeptin and contrast-induced nephropathy in patients with ST-elevation myocardial infarction.
    Yildirim E; Cabbar AT
    Rev Port Cardiol (Engl Ed); 2019 Dec; 38(12):873-879. PubMed ID: 32165078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of radial versus femoral access with contrast-induced acute kidney injury in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Kolte D; Spence N; Puthawala M; Hyder O; Tuohy CP; Davidson CB; Sheldon MW; Laskey WK; Abbott JD
    Cardiovasc Revasc Med; 2016 Dec; 17(8):546-551. PubMed ID: 27566903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-Induced Nephropathy in STEMI Patients With and Without Chronic Kidney Disease.
    Jain T; Shah S; Shah J; Jacobsen G; Khandelwal A
    Crit Pathw Cardiol; 2018 Mar; 17(1):25-31. PubMed ID: 29432373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial).
    Bolognese L; Falsini G; Schwenke C; Grotti S; Limbruno U; Liistro F; Carrera A; Angioli P; Picchi A; Ducci K; Pierli C
    Am J Cardiol; 2012 Jan; 109(1):67-74. PubMed ID: 21943940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragmented QRS complex predicts contrast-induced nephropathy and in-hospital mortality after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.
    Kurtul A; Duran M
    Clin Cardiol; 2017 Apr; 40(4):235-242. PubMed ID: 28244599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel risk score model for prediction of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Lin KY; Zheng WP; Bei WJ; Chen SQ; Islam SM; Liu Y; Xue L; Tan N; Chen JY
    Int J Cardiol; 2017 Mar; 230():402-412. PubMed ID: 28043662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined impact of chronic kidney disease and contrast-induced nephropathy on long-term outcomes in patients with ST-segment elevation acute myocardial infarction who undergo primary percutaneous coronary intervention.
    Nakahashi H; Kosuge M; Sakamaki K; Kiyokuni M; Ebina T; Hibi K; Tsukahara K; Iwahashi N; Kuji S; Oba MS; Umemura S; Kimura K
    Heart Vessels; 2017 Jan; 32(1):22-29. PubMed ID: 27106917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The investigation of TIMI risk index for prediction of contrast-induced acute kidney injury in patients with ST elevation myocardial infarction.
    Çınar T; Karabağ Y; Ozan Tanık V; Çağdaş M; Rencüzoğulları İ; Öz A
    Acta Cardiol; 2020 Feb; 75(1):77-84. PubMed ID: 30678606
    [No Abstract]   [Full Text] [Related]  

  • 17. The Value of d-Dimer Level in Predicting Contrast-Induced Acute Kidney Injury in Patients With Acute ST-Segment Elevation Myocardial Infarction After PCI.
    Luo E; Wang D; Liu B; Hou J; Yan G; Tang C
    Clin Appl Thromb Hemost; 2020; 26():1076029620944492. PubMed ID: 33032448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of combination therapy of statin and N-acetylcysteine for the prevention of contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Park SH; Jeong MH; Park IH; Choi JS; Rhee JA; Kim IS; Kim MC; Cho JY; Sim DS; Hong YJ; Park HW; Kim JH; Ahn Y; Cho JG; Park JC; Kang JC
    Int J Cardiol; 2016 Jun; 212():100-6. PubMed ID: 27045874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, Predictors, and Impact on Six-Month Mortality of Three Different Definitions of Contrast-Induced Acute Kidney Injury After Coronary Angiography.
    Guillon B; Ecarnot F; Marcucci C; Ducloux D; Chatot M; Badoz M; Bonnet B; Chopard R; Frey P; Meneveau N; Schiele F
    Am J Cardiol; 2018 Apr; 121(7):818-824. PubMed ID: 29397881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between prophylactic hydration volume and risk of contrast-induced nephropathy after emergent percutaneous coronary intervention.
    Cui T; Zhao J; Bei W; Li H; Tan N; Wu D; Wang K; Guo X; Liu Y; Duan C; Chen S; Lin K; Liu Y
    Cardiol J; 2017; 24(6):660-670. PubMed ID: 28394010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.